Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.52 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.52 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.52 |
| ▸ | EDNRA | P25101 | 1/20 | 0.49 |
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.48 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.47 |
| ▸ | REN | P00797 | 2/20 | 0.47 |
| ▸ | GLP1R | P43220 | 6/20 | 0.46 |
| ▸ | GHSR | Q92847 | 1/20 | 0.46 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29443916 | 0.86 | GLP1R (0.61) | GLP1R | |
| SCHEMBL31442161 | 0.84 | EDNRA (0.51) | EDNRARENGHSRKISS1R | |
| SCHEMBL30360572 | 0.82 | ACE (0.59) | GHSR | |
| SCHEMBL31442128 | 0.82 | GHSR (0.54) | CALCRLGHSRKISS1R | |
| SCHEMBL1370359 | 0.81 | GHSR (0.59) | RENGLP1RGHSRKISS1R | |
| SCHEMBL1370378 | 0.81 | GHSR (0.59) | RENGLP1RGHSRKISS1R | |
| SCHEMBL31462007 | 0.81 | REN (0.59) | MAPK8MAPK9MAPK10REN | |
| SCHEMBL31442130 | 0.81 | GHSR (0.55) | EDNRARENGHSRKISS1R | |
| SCHEMBL31442238 | 0.81 | GHSR (0.55) | CALCRLGHSRKISS1R | |
| SCHEMBL30223334 | 0.81 | GHSR (0.57) | EDNRAGHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119899278-A | Chimeric cytokine receptor gene modification enhanced cell therapy model, construction method and application thereof | 北京医院 | 2025-04-29 | — | — | CN | disclosed |